Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease

Plasma levels of tau phosphorylated at threonine-217 (p-tau217) is a candidate tool to monitor Alzheimer’s disease. We studied 150 cognitively unimpaired participants and 100 patients with mild cognitive impairment in the Swedish BioFINDER study. P-tau217 was measured repeatedly for up to 6 years (m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Brain
Main Authors: Mattsson-Carlgren, Niklas, Janelidze, Shorena, Palmqvist, Sebastian, Cullen, Nicholas, Svenningsson, Anna L, Strandberg, Olof, Mengel, David, Walsh, Dominic M, Stomrud, Erik, Dage, Jeffrey L, Hansson, Oskar
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7719022/
https://ncbi.nlm.nih.gov/pubmed/33068398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awaa286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados